BioSensory SD A1cCare, Руководство пользователя

Страница: 58 / 61

60
Annex 1: Information for Healthcare Professionals
Protection against infections
There is a potential risk of infection. Medical staff using SD A1cCare™ analyzer to perform
measurements for more than one patient must be aware that any object coming into
contact with human blood is a potential source of infection.
t
Use gloves.
t Apply blood outside the analyzer. When measuring glucose in several persons clean
and disinfect the analyzer before each measurement as blood cannot be applied
using capillary pipettes.
t
When measuring HbA1c in several persons, always use capillary pipettes to apply
blood outside the analyzer.
t
Dispose of used capillary pipettes and test kits in a clinical waste bin.
t
Follow all other locally applicable guidelines and regulations on health and safety.
Annex 2: References
1.
(PMETUFJO%&-JUUMF33-PSFO[3".BMPOF+*/BUIBO%1FUFSTPO$.5FTUTPG
glycemia in diabetes. Diabetes Care 1995; 18:896-909.
2. Bunn HF. Nonenzymatic glycosylation of protein: relevance to diabetes. Am J Med
1981; 70:325-30.
3.
+PWBOPWJD-1FUFSTPO$.5IFDMJOJDBMVUJMJUZPGHMZDPTZMBUFEIFNPHMPCJO"N+.FE
1981; 70:331-8.
4. Nathan DM, Singer DE, Hurxthal K, Goodson JD. The clinical information value of the
glycosylated hemoglobin assay. N EnglJ Med 1984; 310:341-6.
5. Brooks DE, Devine DV, Harris PC, et al. RAMP(TM): A rapid, quantitative whole blood
immunochromatographic platform for point-of-care testing.Clin Chem 1999;45:1676-
1678.
6.
-JUUMF33FUBM3FMBUJPOTIJQPGHMZDPTZMBUFEIFNPHMPCJOUPPSBMHMVDPTFUPMFSBODF
Implications for diabetes screening. Diabetes 1988; 37(1):60-64.